haloperidol has been researched along with paliperidone palmitate in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (5.13) | 18.2507 |
2000's | 4 (10.26) | 29.6817 |
2010's | 24 (61.54) | 24.3611 |
2020's | 9 (23.08) | 2.80 |
Authors | Studies |
---|---|
Janssen, PM; Leysen, JE; Megens, AA; Schotte, A | 1 |
Linnet, K; Olesen, OV | 1 |
DeVane, CL; Donovan, JL; Markowitz, JS; Wang, JS; Zhu, HJ | 1 |
Bartlett, MG; Terry, AV; Zhang, G | 1 |
Awouters, FH; Lewi, PJ | 1 |
Henken, S; Hiemke, C; Kirschbaum, KM; Schmitt, U | 1 |
Alves, I; Nuss, P; Salgado, GF; Staneva, G; Tessier, C | 1 |
Cole-Strauss, A; Jandacek, R; Lipton, JW; McNamara, RK; Rider, T; Tso, P | 1 |
Bernardo, M; Gassó, P; Lafuente, A; Mas, S; Molina, O; Parellada, E | 1 |
Kirk Morton, N; Zubek, D | 1 |
Hsu, CY; Lin, YH; Shen, YC | 1 |
Bø, CN; Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R | 1 |
Goff, DC | 1 |
Buckley, PF; Byerly, M; Dominik, R; Hamer, RM; Lamberti, JS; McEvoy, JP; Ray, N; Rosenheck, RA; Stroup, TS; Swartz, MS; Wilkins, TM | 1 |
Chen, KP; Lung, FW; Yang, MC | 1 |
Cui, X; Li, G; Li, M; Li, Z; Liu, F; Liu, H; Peng, L; Qin, C; Sun, D; Sun, J; Wu, J; Xu, H; Yue, Q; Zhang, J; Zhang, X; Zhu, D | 1 |
Bernard, S; Hugo, N; Kristof, M; Lisbeth, P; Manuel, M; Vincent, H | 1 |
Barbui, C; Ostuzzi, G | 1 |
Hammarlund-Udenaes, M; Jansson, B; König, F; Loryan, I; Melander, E; Payan, M; Svensson, M | 1 |
Bereza, BG; Einarson, TR; Goswami, P; Maia-Lopes, S; Van Impe, K | 1 |
Byerly, MJ; Hamer, RM; Leslie, DL; Li, Y; Lin, H; McEvoy, JP; Rosenheck, RA; Sint, KJ; Stroup, TS; Swartz, MS | 1 |
Alphs, L; Correll, CU; Kim, E; Mao, L; Starr, HL | 1 |
Ide, GD; Khan, AY; Ovais, M; Salaria, S | 1 |
De Vos, C; Decuypere, F; Denee, TR; Geerts, P; Lamotte, M; Malfait, B; Mulder, CL; Sermon, J | 1 |
Bereza, BG; Denee, TR; Dries, PJT; Einarson, TR; Tedouri, F; Van Impe, K | 1 |
Tagne Nouemssi, AB | 1 |
Aguirre, C; Erezuma, I; Garcia, M; Hernandez, R; Lertxundi, U; Medrano, J | 1 |
Bareis, NA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
Ansolabehere, X; Guillon, P; Harmand, S | 1 |
Cho, SW; Choi, G; Joo, SW; Koh, M; Lee, J; Shon, SH | 1 |
Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S | 1 |
Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
Byeon, SJ; Chung, SJ; Oh, S | 1 |
Osman, E; Yıldız, M | 1 |
Arango, C; Leucht, S; Lopez-Morinigo, JD | 1 |
Fujii, Y; Misawa, F; Takeuchi, H | 1 |
Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
Akazawa, M; Inada, K; Okada, Y | 1 |
7 review(s) available for haloperidol and paliperidone palmitate
Article | Year |
---|---|
Forty years of antipsychotic Drug research--from haloperidol to paliperidone--with Dr. Paul Janssen.
Topics: Antipsychotic Agents; Haloperidol; History, 20th Century; History, 21st Century; Humans; Isoxazoles; Paliperidone Palmitate; Pimozide; Psychotic Disorders; Pyrimidines; Risperidone; Structure-Activity Relationship | 2007 |
Depot antipsychotics: Where do we stand?
Topics: Antipsychotic Agents; Haloperidol; Hospitalization; Humans; Medication Adherence; Paliperidone Palmitate; Schizophrenia | 2016 |
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes | 2020 |
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Humans; Lurasidone Hydrochloride; Molindone; Olanzapine; Paliperidone Palmitate; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Systematic Reviews as Topic | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
5 trial(s) available for haloperidol and paliperidone palmitate
Article | Year |
---|---|
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Schizophrenia; Treatment Failure; Treatment Outcome; Weight Gain | 2014 |
Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Clopenthixol; Cytochrome P-450 CYP2D6; Drug Monitoring; Drug Therapy, Combination; Female; Genotype; Haloperidol; Humans; Male; Middle Aged; Paliperidone Palmitate; Young Adult | 2016 |
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cost-Benefit Analysis; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Injections; Male; Middle Aged; Outcome Assessment, Health Care; Paliperidone Palmitate; Patient Acceptance of Health Care; Psychotic Disorders; Quality-Adjusted Life Years; Schizophrenia; United States; Young Adult | 2016 |
Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Delayed-Action Preparations; Female; Haloperidol; Humans; Hyperprolactinemia; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Perphenazine; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Failure; Treatment Outcome | 2016 |
Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Age Factors; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Progression-Free Survival; Schizophrenia; Treatment Failure; Young Adult | 2018 |
27 other study(ies) available for haloperidol and paliperidone palmitate
Article | Year |
---|---|
Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
Topics: Animals; Antipsychotic Agents; Brain; Clone Cells; Clozapine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Haloperidol; Humans; Isoxazoles; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Serotonin Antagonists | 1994 |
Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in serum from patients comedicated with other psychotropic drugs.
Topics: Antipsychotic Agents; Artifacts; Chromatography, High Pressure Liquid; Haloperidol; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Spectrophotometry, Ultraviolet | 1997 |
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodiazepines; Chlorpromazine; Clozapine; Cyclosporins; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Flow Cytometry; Fluorescent Dyes; Haloperidol; Isoxazoles; Kidney; Liver; LLC-PK1 Cells; Olanzapine; Paliperidone Palmitate; Pyrimidines; Quetiapine Fumarate; Rhodamine 123; Risperidone; Swine; Transfection | 2006 |
Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chromatography, Liquid; Clozapine; Haloperidol; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Rats; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry; Thiazoles | 2007 |
Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in mice.
Topics: Animals; Antipsychotic Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Mice; Mice, Knockout; Motor Activity; Paliperidone Palmitate; Pyrimidines; Risperidone; Time Factors | 2008 |
The interaction of antipsychotic drugs with lipids and subsequent lipid reorganization investigated using biophysical methods.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antipsychotic Agents; Calorimetry, Differential Scanning; Cell Membrane; Cholesterol; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Isoxazoles; Membrane Lipids; Membranes, Artificial; Microscopy, Fluorescence; Models, Molecular; Molecular Conformation; Molecular Structure; Paliperidone Palmitate; Phosphatidylcholines; Pyrimidines; Receptors, Dopamine D2; Risperidone; Sphingomyelins; Structure-Activity Relationship; Surface Plasmon Resonance; X-Ray Diffraction | 2011 |
Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drinking Water; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Haloperidol; Isoxazoles; Linoleoyl-CoA Desaturase; Liver; Male; Olanzapine; Paliperidone Palmitate; Pyrimidines; Quetiapine Fumarate; Rats; Rats, Long-Evans; Risperidone; RNA, Messenger | 2011 |
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells.
Topics: Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Humans; Isoxazoles; Neuroblastoma; Neuroprotective Agents; Paliperidone Palmitate; Pyrimidines; Risperidone | 2012 |
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia | 2013 |
Tardive dyskinesia induced by a switch from haloperidol depot to paliperidone palmitate.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Isoxazoles; Paliperidone Palmitate; Palmitates; Schizophrenia | 2013 |
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Female; Haloperidol; Health Care Costs; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Models, Econometric; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Sweden | 2014 |
Maintenance treatment with long-acting injectable antipsychotics: comparing old with new.
Topics: Antipsychotic Agents; Female; Haloperidol; Humans; Isoxazoles; Male; Paliperidone Palmitate; Palmitates | 2014 |
Generalized estimating equation model and long-term exposure effect of antipsychotics on SH-SY5Y cells against oxidative stressors.
Topics: 1-Methyl-4-phenylpyridinium; Amyloid beta-Peptides; Antipsychotic Agents; Benzodiazepines; Cell Line, Tumor; Cell Survival; Glutathione; Haloperidol; Humans; Hydrogen Peroxide; Models, Biological; Neuroprotective Agents; Olanzapine; Oxidative Stress; Paliperidone Palmitate; Peptide Fragments; Protein Carbonylation; Risperidone | 2014 |
Paliperidone protects SK-N-SH cells against glutamate toxicity via Akt1/GSK3β signaling pathway.
Topics: Antipsychotic Agents; Apoptosis; Cell Enlargement; Cell Line, Tumor; Cell Survival; Chromones; Enzyme Inhibitors; Gene Expression; Glutamic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Haloperidol; Humans; Isoxazoles; L-Lactate Dehydrogenase; Morpholines; Neuroprotective Agents; Paliperidone Palmitate; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Reactive Oxygen Species; RNA, Messenger; Signal Transduction | 2014 |
Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised study.
Topics: Antipsychotic Agents; Haloperidol; Humans; Paliperidone Palmitate; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia | 2016 |
In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy.
Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; Benzodiazepines; Blood-Brain Barrier; Brain; Cerebrospinal Fluid; Clozapine; Haloperidol; Male; Neuropharmacology; Olanzapine; Paliperidone Palmitate; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Risperidone | 2016 |
Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Delayed-Action Preparations; Haloperidol; Hospitalization; Humans; Olanzapine; Paliperidone Palmitate; Portugal; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia | 2016 |
Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.
Topics: Adult; Antipsychotic Agents; Belgium; Benzodiazepines; Delayed-Action Preparations; Drug Administration Schedule; Female; Haloperidol; Humans; Medication Adherence; Netherlands; Olanzapine; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2017 |
Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Delayed-Action Preparations; Haloperidol; Humans; Netherlands; Olanzapine; Paliperidone Palmitate; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia | 2017 |
Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability.
Topics: Antipsychotic Agents; Autonomic Nervous System; Cardiovascular Diseases; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Male; Paliperidone Palmitate; Risperidone; Schizophrenia; Tachycardia, Sinus; Treatment Outcome; Young Adult | 2018 |
Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Child; Databases, Factual; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Pharmacovigilance; Pituitary Neoplasms; Pregnancy; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sulpiride; Young Adult | 2019 |
Real-life persistence of long-acting injectable antipsychotics in schizophrenic patients: A retrospective observational study in France
.
Topics: Antipsychotic Agents; Delayed-Action Preparations; France; Haloperidol; Humans; Injections; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia | 2019 |
Continuation of schizophrenia treatment with three long-acting injectable antipsychotics in South Korea: A nationwide population-based study.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections; Male; Paliperidone Palmitate; Patient Acceptance of Health Care; Republic of Korea; Risperidone; Schizophrenia | 2019 |
Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Drug-Related Side Effects and Adverse Reactions; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2022 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan.
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Japan; Paliperidone Palmitate; Risperidone; Schizophrenia; Tardive Dyskinesia | 2022 |
Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan.
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Japan; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia | 2023 |